|
Dr. Snyder received his doctorate in clinical psychology and behavioral neuroscience, from Michigan State University in 1992, following an internship in clinical neuropsychology at the Long Island Jewish Medical Center (New York, USA). Dr. Snyder received a Wilder Penfield Research Fellowship in 1992 from the Epilepsy Foundation of America, and he served as a Clinical Neurosciences Fellow in the NIMH Clinical Research Center for the Study of Schizophrenia at Hillside Hospital (Albert Einstein College of Medicine) in 1992 and 1993. He serves as an Associate Editor of Brain and Cognition, and he has delivered over 100 presentations at international scientific conferences. From 1998 to 2005, Dr. Snyder was employed as a scientist, clinician and manager at Pfizer Global Research & Development Groton Laboratories (Connecticut, USA) the largest research laboratory of Pfizer, Inc. Dr. Snyder was responsible for the identification and development of novel clinical technologies for the CNS therapeutic area at Pfizer. Then, as a Director and Early Clinical Leader, Dr. Snyder led the early clinical development of novel compounds for the treatment of schizophrenia and Alzheimer’s disease at Pfizer, Inc. Dr. Snyder left Pfizer in late 2005, to return to academia as a Professor (with tenure) in the Department of Psychology at the University of Connecticut (Storrs, CT). Dr. Snyder teaches graduate courses in cognitive neuroscience and clinical neuropsychology, he maintains an active laboratory, and he serves as the major professor for several graduate and post-doctoral students. Dr. Snyder consults to several private corporations, and he is an active adjunct faculty member in the Yale Child Study Center, Yale University School of Medicine. | 